GuidelineGlobal health action2014
Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology.
Guideline in Global health action, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
69 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Budgeting for Environmental Health Services in Healthcare Facilities: A Ten-Step Model for Planning and Costing.International journal of environmental research and public health · 2020Pooled it
- Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review.BMC health services research · 2018Pooled it
- Conduction System Pacing vs Biventricular Pacing in Chronic Heart Failure: Protocol for the Economic Analysis of the PhysioSync-HF Trial.Arquivos brasileiros de cardiologia · 2025Trial
- Cost-effectiveness of a short-course antibiotic treatment strategy for the treatment of ventilator-associated pneumonia: an economic analysis of the REGARD-VAP trial.The Lancet. Global health · 2024Trial
- Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial.Bulletin of the World Health Organization · 2020Trial
- Estimating System-Wide Healthcare Costs Using a Health System Model: Application to the Thanzi La Onse Model of Malawi.Applied health economics and health policy · 2026Article
- Article
- Cost analysis for professional oral hygiene management of inpatients in ICU.BMC oral health · 2026Article
- The economic cost of outpatient primary care of adults with multimorbidity (HIV, diabetes, and hypertension) in rural South Africa.Health policy and planning · 2026Article
- Article
- An Introduction to Costing and the Types of Costs Used within Health Economic Studies.PharmacoEconomics - open · 2025Review
- Direct medical cost analysis of breast cancer treatment at Jimma University Medical Center: a provider perspective.Cost effectiveness and resource allocation : C/E · 2025Article
- Estimating the economic and societal burden of suicide and suicide attempts in India: a study protocol.BMJ open · 2025Article
- Micro-costing analysis of a community-based psychiatric intervention among people who inject drugs in Haiphong, Vietnam.Frontiers in psychiatry · 2025Article
- Unit costs of health services provided at hospitals and health centres in two provinces of Zambia.GHM open · 2024Article
- Article
- The economic burden of type 2 diabetes on the public healthcare system in Kenya: a cost of illness study.BMC health services research · 2024Article
- Internal Audit of an Oral Pathology Laboratory: Perspectives on Finances and Operational Management.Cureus · 2024Article
- Estimating the cost for obstetric fistula repair in hospitals of Mozambique: a low-income country.Health economics review · 2024Article
- Article
9 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDisease-specific costing studies can be used as input into cost-effectiveness analyses and provide important information for efficient resource allocation. However, limited data availability and limited expertise constrain such studies in low- and middle-income countries (LMICs).
objectiveTo describe a step-by-step guideline for conducting disease-specific costing studies in LMICs where data availability is limited and to illustrate how the guideline was applied in a costing study of cardiovascular disease prevention care in rural Nigeria.
designThe step-by-step guideline provides practical recommendations on methods and data requirements for six sequential steps: 1) definition of the study perspective, 2) characterization of the unit of analysis, 3) identification of cost items, 4) measurement of cost items, 5) valuation of cost items, and 6) uncertainty analyses.Please provide the significance of asterisk given in table body.
resultsWe discuss the necessary tradeoffs between the accuracy of estimates and data availability constraints at each step and illustrate how a mixed methodology of accurate bottom-up micro-costing and more feasible approaches can be used to make optimal use of all available data. An illustrative example from Nigeria is provided.
conclusionsAn innovative, user-friendly guideline for disease-specific costing in LMICs is presented, using a mixed methodology to account for limited data availability. The illustrative example showed that the step-by-step guideline can be used by healthcare professionals in LMICs to conduct feasible and accurate disease-specific cost analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.